RecruitingNot applicableNCT07498959

Primary RPLND Versus Systemic Chemotherapy in Good-prognosis Metastatic Testicular Cancer

Studying Germ cell tumor of testis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Sahlgrenska University Hospital
Intervention
primary RPLND for low-stage metasatatic seminoma(procedure)
Enrollment
160 enrolled
Eligibility
18 years · MALE
Timeline
2026 – 2032

Study locations (1)

Collaborators

Karolinska University Hospital · Haukeland University Hospital · University Hospital of North Norway · Oslo University Hospital · Trondheim University Hospital · Uppsala University Hospital · Norrlands Universitetssjukhus, Umea, Sweden · Lund University Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07498959 on ClinicalTrials.gov

Other trials for Germ cell tumor of testis

Additional recruiting or active studies for the same condition.

See all trials for Germ cell tumor of testis →

← Back to all trials